Skip to main content
Livermore
Livermore
ZHEN

Tobam

SEC CIK
0001527488
Latest filing
Jul 31, 2026

The latest 13F from Tobam covers Q2 2026 (filed Jul 31, 2026): 258 long positions worth $411.9M. The top 10 holdings make up 22.1% of the portfolio, and the largest is NVIDIA Corp (NVDA) at 3.2%. Livermore has 23 filings on Form 13F from this institution, going back to Q1 2021.

What changed in Q2 2026

Share counts compared with Q1 2026: how many positions were new, added to, reduced or sold out, and the biggest buys and sells. Dollar amounts are estimated at the quarter-end prices implied by the filing.

Full comparison
New
38
Est. +$16.2M
Added
108
Est. +$67.4M
Reduced
97
Est. −$70.1M
Sold out
30
Est. −$12.7M

Top 5 holdings

Share of this quarter's portfolio value

  1. NVDANVIDIA Corp
    3.2%$13.1MHistory
  2. GOOGLAlphabet Inc.
    2.9%$12.1MHistory
  3. AAPLApple Inc.
    2.2%$9.00MHistory
  4. EDConsolidated Edison Inc
    2.1%$8.81MHistory
  5. TMUST-Mobile US, Inc.
    2.0%$8.41MHistory

Biggest buys

New and added positions, by estimated amount bought

  1. AMDAdvanced Micro Devices Inc
    +$3.41MAddedHistory
  2. AWKAmerican Water Works Company, Inc.
    +$3.12MAddedHistory
  3. TMUST-Mobile US, Inc.
    +$2.92MAddedHistory
  4. BF.BBrown Forman Corp
    +$2.60MAddedHistory
  5. AMPAmeriprise Financial Inc
    +$2.54MAddedHistory

Largest weight increases

New and added positions, by percentage points of the portfolio gained

  1. AMDAdvanced Micro Devices Inc
    +0.99 pp0.1% → 1.1%History
  2. AWKAmerican Water Works Company, Inc.
    +0.69 pp0.7% → 1.4%History
  3. BF.BBrown Forman Corp
    +0.62 pp0.2% → 0.8%History
  4. AMPAmeriprise Financial Inc
    +0.62 pp<0.1% → 0.6%History
  5. CAHCardinal Health Inc
    +0.61 pp1.2% → 1.8%History

Biggest sells

Reduced and sold-out positions, by estimated amount sold

  1. ALABAstera Labs, Inc.
    −$5.64MReducedHistory
  2. METAMeta Platforms, Inc.
    −$4.58MReducedHistory
  3. DGDollar General Corp
    −$3.53MReducedHistory
  4. CNCCentene Corp
    −$3.11MReducedHistory
  5. WSTWest Pharmaceutical Services Inc
    −$3.10MReducedHistory

Largest weight decreases

Reduced and sold-out positions, by percentage points of the portfolio lost

  1. METAMeta Platforms, Inc.
    −1.22 pp1.3% → 0.1%History
  2. DGDollar General Corp
    −0.96 pp1.1% → 0.1%History
  3. AMTAmerican Tower Corp
    −0.54 pp1.1% → 0.6%History
  4. GMGeneral Motors Co
    −0.50 pp1.4% → 0.9%History
  5. MDLZMondelez International, Inc.
    −0.48 pp1.1% → 0.6%History

Metrics

13F metrics for Q2 2026, computed only from the numbers in the filings. Definitions below.

Portfolio value
$411.9M
+$27.8M (+7.2%) vs. prior quarter
Positions
258
+8 vs. prior quarter
Top 10 concentration
22.1%
Top 10 as share of value
Turnover
20.8%
Q2 2026, one quarter
Average holding period
14.9 quarters
Weighted by value

How these are calculated

  • Portfolio value: the market value of all long positions in the 13F, as reported at quarter end, excluding options.
  • Top 10 concentration: the combined value of the 10 largest positions as a share of portfolio value.
  • Turnover: the smaller of this quarter's estimated purchases and estimated sales, divided by the average of this and last quarter's portfolio value. Estimates multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares); new positions use this quarter's value and sold-out positions last quarter's. Only positions reported in shares count, and it is not calculated when the previous quarter was not filed.
  • Average holding period: how many consecutive quarters each current position has been held (including this one; a quarter without the position or without a filing starts the count over), weighted by this quarter's value. Counting starts with the first 13F in Livermore (Q1 2021), so positions held before then are understated.

13F filings by quarter

22 quarters, going back to Q1 2021. Bars show each quarter's 13F portfolio value; quarters without a filing are left blank.

Peak $2.50B (Q2 2021)

Q1 2021: $2.35BQ2 2021: $2.50BQ3 2021: $2.36BQ4 2021: $2.22BQ1 2022: $1.99BQ2 2022: $1.60BQ3 2022: $1.43BQ4 2022: $1.51BQ1 2023: $1.52BQ2 2023: $1.33BQ3 2023: $1.25BQ4 2023: $1.14BQ1 2024: $1.12BQ2 2024: $637.8MQ3 2024: $548.4MQ4 2024: $327.7MQ1 2025: $234.0MQ2 2025: $256.2MQ3 2025: $276.0MQ4 2025: $407.2MQ1 2026: $384.2MQ2 2026: $411.9M
Q1 2021Q2 2026
13F filings of Tobam by quarter
QuarterFiledPositionsValueTop 3 holdingsChangesFiling
Q2 2026Jul 31, 2026258$411.9MNVDAGOOGLAAPLvs. Q1 2026SEC
Q1 2026May 12, 2026250$384.2MNVDAGOOGLEDvs. Q4 2025SEC
Q4 2025Mar 2, 2026255$407.2MNVDAGOOGLAVGOvs. Q3 2025SEC
Q3 2025Nov 7, 2025247$276.0MMSTREDHSYvs. Q2 2025SEC
Q2 2025Aug 8, 2025253$256.2MCBOETVZvs. Q1 2025SEC
Q1 2025Apr 16, 2025251$234.0MTCBOEVZvs. Q4 2024SEC
Q4 2024Jan 28, 2025319$327.7MTGISMCKvs. Q3 2024SEC
Q3 2024Oct 9, 2024319$548.4MTGISCBOEvs. Q2 2024SEC
Q2 2024Aug 1, 2024Amended326$637.8MLLYTUTHRvs. Q1 2024SEC
Q1 2024May 2, 2024377$1.12BLLYGISABBVvs. Q4 2023SEC
Q4 2023Jan 26, 2024374$1.14BABBVMRKLLYvs. Q3 2023SEC
Q3 2023Oct 31, 2023376$1.25BABBVMRKJNJvs. Q2 2023SEC
Q2 2023Jul 31, 2023359$1.33BMRKKGISvs. Q1 2023SEC
Q1 2023May 3, 2023360$1.52BGISMRKPFEvs. Q4 2022SEC
Q4 2022Feb 2, 2023406$1.51BPFEMRKGISvs. Q3 2022SEC
Q3 2022Nov 2, 2022430$1.43BMRKPFEGISvs. Q2 2022SEC
Q2 2022Aug 2, 2022429$1.60BPFEGISKMBvs. Q1 2022SEC
Q1 2022Apr 25, 2022429$1.99BGISPFELLYvs. Q4 2021SEC
Q4 2021Feb 15, 2022435$2.22BGISGILDLLYvs. Q3 2021SEC
Q3 2021Nov 12, 2021429$2.36BGILDGISCLXvs. Q2 2021SEC
Q2 2021Aug 11, 2021433$2.50BGILDCLXGISvs. Q1 2021SEC
Q1 2021May 11, 2021427$2.35BGILDCLXCAG–SEC